Ursodeoxycholic acid for primary biliary cirrhosis (multiple letters)

Lancet

Volumn 355, Issue 9204, 2000, Pages 657-658

  Lindor, Keith D ^a   Poupon, Raoul ^b,c,d   Poupon, Renee ^b,c,d   Heathcote, E Jenny ^b,c,d   Therneau, Terry ^b,c,d  

^a MAYO CLINIC   (United States)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSERM   (France)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID; CHOLAGOGUE;

CLINICAL TRIAL; HUMAN; LETTER; META ANALYSIS; METHODOLOGY; OUTCOMES RESEARCH; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; BILIARY CIRRHOSIS; NOTE;

CHOLAGOGUES AND CHOLERETICS; HUMANS; LIVER CIRRHOSIS, BILIARY; META-ANALYSIS; URSODEOXYCHOLIC ACID;

EID: 0034685121     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)72401-6     Document Type: Letter

References (5)

1. J Goulis G Leandro AK Burroughs Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis Lancet 354 1999 1053 1060
2. R Der Simonian N Laird Meta-analysis in clinical trials Contr Clin Trials 7 1986 177 188
3. Pares A,Caballeria L,Rodes J, et al.Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind, controlled multicentre trial. J Hepatol (in press).
4. MR Kilmurry JE Heathcote K Cauch-Dudek Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology 23 1996 1148 1153
5. KD Lindor ER Dickson WP Baldus Ursodeoxycholic acid in the treatment of primary biliary cirrhosis Gastroenterology 106 1994 1284 1290